CME Group (CME) Projected to Post Quarterly Earnings on Wednesday

Key Points

• CME Group is set to announce its Q3 2025 earnings on October 22, expecting earnings of $2.73 per share and revenue of $1.5621 billion.
• The company recently paid a quarterly dividend of $1.25 per share, representing a 1.9% yield and an annualized dividend of $5.00.
• CME Group's stock has seen varied analyst ratings, with the current consensus rating being "Hold" and an average price target of $283.71.

CME Group (NASDAQ:CME - Get Free Report) is expected to issue its Q3 2025 results before the market opens on Wednesday, October 22nd. Analysts expect the company to announce earnings of $2.73 per share and revenue of $1.5621 billion for the quarter. Parties can find conference call details on the company's upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Wednesday, October 22, 2025 at 8:30 AM ET.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.05. The firm had revenue of $1.69 billion for the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.56 earnings per share. On average, analysts expect CME Group to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.

CME Group Price Performance

Shares of CME Group stock opened at $267.18 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $96.29 billion, a price-to-earnings ratio of 25.86, a P/E/G ratio of 6.23 and a beta of 0.41. CME Group has a 1-year low of $213.94 and a 1-year high of $290.79. The firm's 50-day moving average price is $268.22 and its two-hundred day moving average price is $271.32.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.

Analyst Upgrades and Downgrades

CME has been the topic of several research analyst reports. Oppenheimer upped their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research note on Sunday, July 13th. Jefferies Financial Group decreased their price target on shares of CME Group from $313.00 to $304.00 and set a "buy" rating on the stock in a research note on Friday, October 10th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $252.00 to $256.00 and gave the company an "underweight" rating in a research note on Tuesday. Finally, Keefe, Bruyette & Woods increased their price target on shares of CME Group from $283.00 to $287.00 and gave the company a "market perform" rating in a research note on Monday. Seven equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, CME Group currently has an average rating of "Hold" and a consensus price target of $283.71.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction on Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the purchase, the director owned 258,459 shares in the company, valued at $68,540,742.21. The trade was a 0.10% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last three months. Insiders own 0.30% of the company's stock.

Hedge Funds Weigh In On CME Group

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. ICW Investment Advisors LLC raised its holdings in CME Group by 6.3% in the second quarter. ICW Investment Advisors LLC now owns 1,304 shares of the financial services provider's stock worth $359,000 after purchasing an additional 77 shares during the period. Keel Point LLC boosted its position in shares of CME Group by 9.8% during the second quarter. Keel Point LLC now owns 1,423 shares of the financial services provider's stock worth $392,000 after purchasing an additional 127 shares in the last quarter. Sompo Asset Management Co. Ltd. boosted its position in shares of CME Group by 5.5% during the second quarter. Sompo Asset Management Co. Ltd. now owns 2,490 shares of the financial services provider's stock worth $686,000 after purchasing an additional 130 shares in the last quarter. Modern Wealth Management LLC boosted its position in shares of CME Group by 1.4% during the second quarter. Modern Wealth Management LLC now owns 12,544 shares of the financial services provider's stock worth $3,457,000 after purchasing an additional 174 shares in the last quarter. Finally, Smartleaf Asset Management LLC boosted its position in shares of CME Group by 4.0% during the second quarter. Smartleaf Asset Management LLC now owns 4,662 shares of the financial services provider's stock worth $1,281,000 after purchasing an additional 178 shares in the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.